452 related articles for article (PubMed ID: 18980207)
21. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
22. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
[TBL] [Abstract][Full Text] [Related]
23. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
24. Recruitment of natural killer cells in advanced stages of endogenously arising B-cell lymphoma: implications for therapeutic cell transfer.
Przewoznik M; Hömberg N; Naujoks M; Pötzl J; Münchmeier N; Brenner CD; Anz D; Bourquin C; Nelson PJ; Röcken M; Mocikat R
J Immunother; 2012 Apr; 35(3):217-22. PubMed ID: 22421939
[TBL] [Abstract][Full Text] [Related]
25. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes.
Korniejewska A; Watson M; Ward S
Methods Mol Biol; 2010; 616():125-47. PubMed ID: 20379873
[TBL] [Abstract][Full Text] [Related]
26. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
27. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
29. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
30. Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?
Haas M; Büttner M; Rau TT; Fietkau R; Grabenbauer GG; Distel LV
Virchows Arch; 2011 Apr; 458(4):403-11. PubMed ID: 21359545
[TBL] [Abstract][Full Text] [Related]
31. Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism.
Ohshima K; Suefuji H; Karube K; Hamasaki M; Hatano B; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kikuchi M
Leuk Lymphoma; 2003 Feb; 44(2):329-36. PubMed ID: 12688353
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of CXCR3-binding chemokines in type 1 diabetes.
Brück P; Bartsch W; Penna-Martinez M; Kahles H; Seidl C; Böhme A; Badenhoop K; Ramos-Lopez E
Hum Immunol; 2009 Jul; 70(7):552-5. PubMed ID: 19410617
[TBL] [Abstract][Full Text] [Related]
33. Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: Involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor.
Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Cattini L; Grassi F; Facchini A
J Cell Physiol; 2004 Mar; 198(3):388-98. PubMed ID: 14755544
[TBL] [Abstract][Full Text] [Related]
34. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation.
Groom JR; Richmond J; Murooka TT; Sorensen EW; Sung JH; Bankert K; von Andrian UH; Moon JJ; Mempel TR; Luster AD
Immunity; 2012 Dec; 37(6):1091-103. PubMed ID: 23123063
[TBL] [Abstract][Full Text] [Related]
35. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
36. Expression of IFN-gamma induced CXCR3 agonist chemokines and compartmentalization of CXCR3+ cells in the periphery and lymph nodes of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC; Reinhart TA
J Med Primatol; 2003 Aug; 32(4-5):247-64. PubMed ID: 14498985
[TBL] [Abstract][Full Text] [Related]
37. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer.
Battaglia A; Buzzonetti A; Baranello C; Ferrandina G; Martinelli E; Fanfani F; Scambia G; Fattorossi A
Cancer Immunol Immunother; 2009 Sep; 58(9):1363-73. PubMed ID: 19172271
[TBL] [Abstract][Full Text] [Related]
38. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
39. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
40. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.
Redjimi N; Raffin C; Raimbaud I; Pignon P; Matsuzaki J; Odunsi K; Valmori D; Ayyoub M
Cancer Res; 2012 Sep; 72(17):4351-60. PubMed ID: 22798340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]